
companies
Pfizer to buy stake in French vaccine companyÂ
The healthcare giant has agreed to invest âŹ90.5m to buy an 8.1% stake in Valneva as the companies announced developments in their partnership to tackle Lyme disease.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC